Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Surface Oncology Inc (SURF)
NASDAQ:SURF
Holding SURF?
Track your performance easily
See the Price Targets and Ratings of:
SURF Analyst Ratings
Hold
0 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SURF Stock 12 Month Forecast
Average Price Target
$2.38
▲(122.43% Upside)
| Highest Price Target$5.00 | Average Price Target$2.38 | Lowest Price Target$1.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
―
Hold
―
Downgraded
06/20/23
Surface Oncology (SURF) was downgraded to a Hold Rating at JonesTrading - TipRanks.com
H.C. Wainwright
$5
Hold
367.29%
Upside
Downgraded
06/20/23
Analysts Conflicted on These Healthcare Names: Calliditas Therapeutics (NASDAQ: CALT), Surface Oncology (NASDAQ: SURF) and Crinetics Pharmaceuticals (NASDAQ: CRNX)
Robert W. Baird
$1
Hold
-6.54%
Downside
Downgraded
06/20/23
Surface Oncology (SURF) was downgraded to a Hold Rating at JonesTrading - TipRanks.comSurface Oncology has an analyst consensus of Hold, with a price target consensus of $2.38, implying a 183.33% upside from current levels. In a report released today, Robert W. Baird also downgraded the stock to a Hold with a $1.00 price target.
Wedbush
$1.15
Hold
7.48%
Upside
Downgraded
06/19/23
Wedbush downgrades Surface Oncology (SURF) to NeutralWedbush analyst Robert Driscoll downgraded Surface Oncology (NASDAQ: SURF) from Outperform to Neutral with a price target of $1.15 (from $3.00).
SURF Analyst Recommendation Trends
Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
SURF Financial Forecast
SURF Stock Forecast FAQ
What is SURF’s average 12-month price target, according to analysts?
Based on analyst ratings, Surface Oncology Inc’s 12-month average price target is $2.38.
What is SURF’s upside potential, based on the analysts’ average price target?
Surface Oncology Inc has 122.43% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SURF a Buy, Sell or Hold?
Surface Oncology Inc has a consensus rating of Hold which is based on 0 buy ratings, 4 hold ratings and 0 sell ratings.
What is Surface Oncology Inc’s price target?
The average price target for Surface Oncology Inc is $2.38. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $1.00. The average price target represents 122.43% Increase from the current price of $1.07.
The highest analyst price target is $5.00 ,the lowest forecast is $1.00. The average price target represents 122.43% Increase from the current price of $1.07.
What do analysts say about Surface Oncology Inc?
Surface Oncology Inc’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of SURF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.